Mads Krogsgaard Thomsen, Novo Nordisk Foundation CEO (Hollie Adams/Bloomberg via Getty Images)

Flush with cash, No­vo Nordisk Foun­da­tion now plans to rein­vest some GLP-1 prof­its in­to re­gen­er­a­tive med­i­cines

The No­vo Nordisk Foun­da­tion, the ma­jor­i­ty own­er of No­vo Nordisk, plans to put more mon­ey in­to re­gen­er­a­tive med­i­cines, in­clud­ing stem cells and cell ther­a­pies for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.